Ypsomed Holding AG
SIX:YPSN

Watchlist Manager
Ypsomed Holding AG Logo
Ypsomed Holding AG
SIX:YPSN
Watchlist
Price: 357 CHF 2.59% Market Closed
Market Cap: 4.9B CHF
Have any thoughts about
Ypsomed Holding AG?
Write Note

Intrinsic Value

The intrinsic value of one YPSN stock under the Base Case scenario is 434.69 CHF. Compared to the current market price of 357 CHF, Ypsomed Holding AG is Undervalued by 18%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

YPSN Intrinsic Value
434.69 CHF
Undervaluation 18%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Ypsomed Holding AG

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for YPSN cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about YPSN?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
Ypsomed Holding AG

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Ypsomed Holding AG

Provide an overview of the primary business activities
of Ypsomed Holding AG.

What unique competitive advantages
does Ypsomed Holding AG hold over its rivals?

What risks and challenges
does Ypsomed Holding AG face in the near future?

Has there been any significant insider trading activity
in Ypsomed Holding AG recently?

Summarize the latest earnings call
of Ypsomed Holding AG.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Ypsomed Holding AG.

Provide P/S
for Ypsomed Holding AG.

Provide P/E
for Ypsomed Holding AG.

Provide P/OCF
for Ypsomed Holding AG.

Provide P/FCFE
for Ypsomed Holding AG.

Provide P/B
for Ypsomed Holding AG.

Provide EV/S
for Ypsomed Holding AG.

Provide EV/GP
for Ypsomed Holding AG.

Provide EV/EBITDA
for Ypsomed Holding AG.

Provide EV/EBIT
for Ypsomed Holding AG.

Provide EV/OCF
for Ypsomed Holding AG.

Provide EV/FCFF
for Ypsomed Holding AG.

Provide EV/IC
for Ypsomed Holding AG.

Show me price targets
for Ypsomed Holding AG made by professional analysts.

What are the Revenue projections
for Ypsomed Holding AG?

How accurate were the past Revenue estimates
for Ypsomed Holding AG?

What are the Net Income projections
for Ypsomed Holding AG?

How accurate were the past Net Income estimates
for Ypsomed Holding AG?

What are the EPS projections
for Ypsomed Holding AG?

How accurate were the past EPS estimates
for Ypsomed Holding AG?

What are the EBIT projections
for Ypsomed Holding AG?

How accurate were the past EBIT estimates
for Ypsomed Holding AG?

Compare the revenue forecasts
for Ypsomed Holding AG with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Ypsomed Holding AG and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Ypsomed Holding AG against its competitors.

Analyze the profit margins
(gross, operating, and net) of Ypsomed Holding AG compared to its peers.

Compare the P/E ratios
of Ypsomed Holding AG against its peers.

Discuss the investment returns and shareholder value creation
comparing Ypsomed Holding AG with its peers.

Analyze the financial leverage
of Ypsomed Holding AG compared to its main competitors.

Show all profitability ratios
for Ypsomed Holding AG.

Provide ROE
for Ypsomed Holding AG.

Provide ROA
for Ypsomed Holding AG.

Provide ROIC
for Ypsomed Holding AG.

Provide ROCE
for Ypsomed Holding AG.

Provide Gross Margin
for Ypsomed Holding AG.

Provide Operating Margin
for Ypsomed Holding AG.

Provide Net Margin
for Ypsomed Holding AG.

Provide FCF Margin
for Ypsomed Holding AG.

Show all solvency ratios
for Ypsomed Holding AG.

Provide D/E Ratio
for Ypsomed Holding AG.

Provide D/A Ratio
for Ypsomed Holding AG.

Provide Interest Coverage Ratio
for Ypsomed Holding AG.

Provide Altman Z-Score Ratio
for Ypsomed Holding AG.

Provide Quick Ratio
for Ypsomed Holding AG.

Provide Current Ratio
for Ypsomed Holding AG.

Provide Cash Ratio
for Ypsomed Holding AG.

What is the historical Revenue growth
over the last 5 years for Ypsomed Holding AG?

What is the historical Net Income growth
over the last 5 years for Ypsomed Holding AG?

What is the current Free Cash Flow
of Ypsomed Holding AG?

Discuss the annual earnings per share (EPS)
trend over the past five years for Ypsomed Holding AG.

Business Breakdown

Ypsomed Holding AG is a Swiss-based medical technology company that has carved out a niche in the rapidly growing diabetes management and drug delivery market. Founded in 1984, the company initially focused on producing insulin delivery systems but has since expanded its portfolio to include sophisticated pens and pumps that facilitate self-administration of medications. With an emphasis on innovation and user-centered design, Ypsomed has positioned itself as a leader in the development of advanced delivery systems that cater to the evolving needs of patients and healthcare providers alike. The company’s strategic partnerships with pharmaceutical firms enhance its growth trajectory, undersco...

Read More
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Ypsomed Holding AG

Current Assets 341.1m
Cash & Short-Term Investments 52.3m
Receivables 130.5m
Other Current Assets 158.2m
Non-Current Assets 839.9m
Long-Term Investments 2.7m
PP&E 495.2m
Intangibles 305.3m
Other Non-Current Assets 36.7m
Current Liabilities 513.4m
Accounts Payable 25.1m
Accrued Liabilities 59.7m
Short-Term Debt 325.2m
Other Current Liabilities 103.4m
Non-Current Liabilities 45.8m
Other Non-Current Liabilities 45.8m
Efficiency

Earnings Waterfall
Ypsomed Holding AG

Revenue
617.1m CHF
Cost of Revenue
-398.4m CHF
Gross Profit
218.7m CHF
Operating Expenses
-131.8m CHF
Operating Income
86.8m CHF
Other Expenses
-12.5m CHF
Net Income
74.4m CHF

Free Cash Flow Analysis
Ypsomed Holding AG

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

YPSN Profitability Score
Profitability Due Diligence

Ypsomed Holding AG's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional Revenue Growth Forecast
Positive 3-Years Revenue Growth
ROE is Increasing
50/100
Profitability
Score

Ypsomed Holding AG's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

YPSN Solvency Score
Solvency Due Diligence

Ypsomed Holding AG's solvency score is 58/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Long-Term Solvency
Short-Term Solvency
58/100
Solvency
Score

Ypsomed Holding AG's solvency score is 58/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

YPSN Price Targets Summary
Ypsomed Holding AG

Wall Street analysts forecast YPSN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for YPSN is 433.09 CHF with a low forecast of 329.26 CHF and a high forecast of 519.75 CHF.

Lowest
Price Target
329.26 CHF
8% Downside
Average
Price Target
433.09 CHF
21% Upside
Highest
Price Target
519.75 CHF
46% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for YPSN?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for YPSN is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

YPSN Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

Ypsomed Holding AG Logo
Ypsomed Holding AG

Country

Switzerland

Industry

Health Care

Market Cap

4.9B CHF

Dividend Yield

0.28%

Description

Ypsomed Holding AG engages in the development and manufacture of injection systems for self-medication of drugs by patients, most notably used to treat diabetes. The company is headquartered in Burgdorf, Bern and currently employs 1,900 full-time employees. The company went IPO on 2004-09-22. The firm develops and manufactures injection systems for custom-made self-administration, and markets pen needles for the treatment of diabetes, growth disorders or infertility, as well as therapeutic areas. The firm operates two business segments: Injection Systems and Diabetes Care. In the Injection Systems segment, the Company's YDS Ypsomed Delivery Systems offer a range of ready-to-use injection systems for pharmaceutical and biotech companies to administer of drugs or to develop and manufacture them in line with customer requirements. The Diabetes Care segment markets products such as pen needles or insulin pump to diabetics, doctors and health insurance providers. The firm operates its production sites in Burgdorf, Solothurn, Grenchen and Tabor, and sales and distribution network across Europe.

Contact

BERN
Burgdorf
Brunnmattstrasse 6
+41344244111.0
www.ypsomed.com

IPO

2004-09-22

Employees

1 900

Officers

CEO & Member of the Board
Mr. Simon Michel
Chief Financial Officer
Mr. Samuel Kunzli
Chief Operating Officer
Mr. Frank Mengis
Head of Investor Relations
Thomas Kutt
Chief Legal Officer & Secretary
Dr. Nicolas Meyer
Chief Corporate Officer
Mr. Michael Zaugg
Show More
Chief Business Officer of Ypsomed Delivery Systems
Ms. Ulrike Bauer
Chief Business Officer of Ypsomed Diabetes Care
Mr. Sebastien Delarive
Show Less

See Also

Discover More
What is the Intrinsic Value of one YPSN stock?

The intrinsic value of one YPSN stock under the Base Case scenario is 434.69 CHF.

Is YPSN stock undervalued or overvalued?

Compared to the current market price of 357 CHF, Ypsomed Holding AG is Undervalued by 18%.

Back to Top